Development of LPS antagonistic therapeutics: synthesis and evaluation of glucopyranoside-spacer-amino acid motifs

Sophon Kaeothip; Geeta Paranjape; Shana E. Terrill; Aileen F. G. Bongat; Maria L. D. Udan; Teerada Kamkhachorn; Hope L. Johnson; Michael R. Nichols; Alexei V. Demchenko

doi:10.1039/C1RA00145K

Development of LPS antagonistic therapeutics: synthesis and evaluation of glucopyranoside-spacer-amino acid motifs

Sophon Kaeothip, Geeta Paranjape, Shana E. Terrill, Aileen F. G. Bongat, Maria L. D. Udan, Teerada Kamkhachorn, Hope L. Johnson, Michael R. Nichols, Alexei V. Demchenko

University of Missouri-St. Louis

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	RSC Advances
Volume	1
DOIs	https://doi.org/10.1039/C1RA00145K
State	Published - Aug 9 2011

Disciplines

Biochemistry

Access to Document

10.1039/C1RA00145KLicense: Unspecified

c1ra00145k.pdfFinal published version, 473 KBLicense: Unspecified

Cite this

@article{579dcc659d4441b8833233f64a6635b2,

title = "Development of LPS antagonistic therapeutics: synthesis and evaluation of glucopyranoside-spacer-amino acid motifs",

author = "Sophon Kaeothip and Geeta Paranjape and Terrill, {Shana E.} and Bongat, {Aileen F. G.} and Udan, {Maria L. D.} and Teerada Kamkhachorn and Johnson, {Hope L.} and Nichols, {Michael R.} and Demchenko, {Alexei V.}",

note = "Sepsis is a serious medical condition characterized by bacterial infection and a subsequent massive systemic inflammatory response. The release of proinflammatory products and mediators from responding innate immune cells, such as mononuclear phagocytes, directly contributes to the pathogenesis of sepsis. Th",

year = "2011",

month = aug,

day = "9",

doi = "10.1039/C1RA00145K",

language = "American English",

volume = "1",

journal = "RSC Advances",

}

TY - JOUR

T1 - Development of LPS antagonistic therapeutics: synthesis and evaluation of glucopyranoside-spacer-amino acid motifs

AU - Kaeothip, Sophon

AU - Paranjape, Geeta

AU - Terrill, Shana E.

AU - Bongat, Aileen F. G.

AU - Udan, Maria L. D.

AU - Kamkhachorn, Teerada

AU - Johnson, Hope L.

AU - Nichols, Michael R.

AU - Demchenko, Alexei V.

N1 - Sepsis is a serious medical condition characterized by bacterial infection and a subsequent massive systemic inflammatory response. The release of proinflammatory products and mediators from responding innate immune cells, such as mononuclear phagocytes, directly contributes to the pathogenesis of sepsis. Th

PY - 2011/8/9

Y1 - 2011/8/9

UR - http://pubs.rsc.org/en/Content/ArticleLanding/RA/2011/C1RA00145K#!

U2 - 10.1039/C1RA00145K

DO - 10.1039/C1RA00145K

M3 - Article

VL - 1

JO - RSC Advances

JF - RSC Advances

ER -

Development of LPS antagonistic therapeutics: synthesis and evaluation of glucopyranoside-spacer-amino acid motifs

Disciplines

Access to Document

Other files and links

Cite this